•
China-based Xbiome, an AI-driven microbiome drug development company, has announced a strategic alliance with Australia-headquartered ZoHealth. This collaboration focuses on the development of human gut microbiota, precision nutrition, and health product innovation. Core Program Focused on Probiotic ProductsThe core program of the partnership will center around Xbiome’s proprietary bacterial strains,…